Depreciation of Autolus Therapeutics plc from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Autolus Therapeutics plc quarterly and annual Depreciation in USD history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Autolus Therapeutics plc Depreciation for the quarter ending 30 Sep 2025 was $2,100,000, a 11% increase year-over-year.
  • Autolus Therapeutics plc Depreciation for the twelve months ending 30 Sep 2025 was $8,200,000, a 11% increase year-over-year.
  • Autolus Therapeutics plc annual Depreciation for 2024 was $7,600,000, a 15% increase from 2023.
  • Autolus Therapeutics plc annual Depreciation for 2023 was $6,600,000, a 9.6% decline from 2022.
  • Autolus Therapeutics plc annual Depreciation for 2022 was $7,300,000, a 15% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Autolus Therapeutics plc Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,200,000 $2,100,000 +$200,000 +11% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $8,000,000 $2,100,000 +$200,000 +11% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $7,800,000 $2,000,000 +$200,000 +11% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $7,600,000 $2,000,000 +$200,000 +11% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $7,400,000 $1,900,000 +$500,000 +36% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $6,900,000 $1,900,000 +$400,000 +27% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $6,500,000 $1,800,000 -$100,000 -5.3% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $6,600,000 $1,800,000 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $1,400,000 -$400,000 -22% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $1,500,000 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $1,900,000 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024 2024 Q1
Q3 2022 $1,800,000 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q1 2021 $6,200,000 $1,800,000 +$500,000 +38% 01 Jan 2021 31 Mar 2021 6-K 06 May 2021 2021 Q1
Q4 2020 $5,700,000 $1,700,000 +$400,000 +31% 01 Oct 2020 31 Dec 2020 20-F 07 Mar 2023 2022 FY
Q3 2020 $5,300,000 $1,500,000 +$400,000 +36% 01 Jul 2020 30 Sep 2020 6-K 05 Nov 2020 2020 Q3
Q2 2020 $4,900,000 $1,200,000 +$100,000 +9.1% 01 Apr 2020 30 Jun 2020 6-K 06 Aug 2020 2020 Q2
Q1 2020 $4,800,000 $1,300,000 +$200,000 +18% 01 Jan 2020 31 Mar 2020 6-K 06 May 2021 2021 Q1
Q4 2019 $4,600,000 $1,300,000 +$655,000 +102% 01 Oct 2019 31 Dec 2019 20-F 10 Mar 2022 2021 FY
Q3 2019 $3,945,000 $1,100,000 +$800,000 +267% 01 Jul 2019 30 Sep 2019 6-K 05 Nov 2020 2020 Q3
Q2 2019 $3,145,000 $1,100,000 +$600,000 +120% 01 Apr 2019 30 Jun 2019 6-K 06 Aug 2020 2020 Q2
Q1 2019 $2,545,000 $1,100,000 01 Jan 2019 31 Mar 2019 6-K 07 May 2020 2020 Q1
Q4 2018 $645,000 01 Oct 2018 31 Dec 2018 20-F 04 Mar 2021 2020 FY
Q3 2018 $300,000 01 Jul 2018 30 Sep 2018 6-K 07 Nov 2019 2019 Q3
Q2 2018 $500,000 01 Apr 2018 30 Jun 2018 6-K 08 Aug 2019 2019 Q2

Autolus Therapeutics plc Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $7,600,000 +$1,000,000 +15% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $6,600,000 -$700,000 -9.6% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $7,300,000 -$1,300,000 -15% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $8,600,000 +$2,900,000 +51% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2024 2023 FY
2020 $5,700,000 +$1,100,000 +24% 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023 2022 FY
2019 $4,600,000 +$2,891,000 +169% 01 Jan 2019 31 Dec 2019 20-F 10 Mar 2022 2021 FY
2018 $1,709,000 +$700,000 +69% 01 Oct 2017 30 Sep 2018 20-F 03 Mar 2020 2019 FY
2017 $1,009,000 +$531,000 +111% 01 Oct 2016 30 Sep 2017 20-F 03 Mar 2020 2019 FY
2016 $478,000 01 Oct 2015 30 Sep 2016 20-F 25 Feb 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.